Product Description
GSK-2983559 is a potent and selective inhibitor of receptor interacting protein-2 (RIP2) kinase.
GSK-2983559 is a potent and selective inhibitor of receptor interacting protein-2 (RIP2) kinase.
Biovision | B2709 | GSK-2983559 DataSheet
Alternate Name/Synonyms: 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate,GSK2983559
Appearance: Crystalline solid
Formulation:
CAS Number: 1579965-12-0
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₁H₂₃N₄O₇PS₂
Molecular Weight: 538.53
Cell-Permeable?: TRUE
Purity: ≥98% by HPLC
Solubilities: ~5 mg/ml DMSO
Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Country of Origin: USA
Tag Line: A small-molecule RIP2 kinase inhibitor
MDL Number:
PubChem CID: 73386708
SMILES: CC(C)(C)S(=O)(=O)C1=C(C=C2C(=C1)C(=NC=N2)NC3=CC4=C(C=C3)SC=N4)OCCOP(=O)(O)O
InChi: InChI=1S/C21H23N4O7PS2/c1-21(2,3)35(29,30)19-9-14-15(10-17(19)31-6-7-32-33(26,27)28)22-11-23-20(14)25-13-4-5-18-16(8-13)24-12-34-18/h4-5,8-12H,6-7H2,1-3H3,(H,22,23,25)(H2,26,27,28)
InChi Key: MJLYDVMFNHZMLV-UHFFFAOYSA-N